This financial footnotes page serves as your central resource for all supporting details related to Emera Inc.'s financial disclosures that are highlighted on our investor relations webpages. Here, you’ll find comprehensive footnotes that provide context and clarity to the financial information. These notes are updated in alignment with our financial publications to ensure investors have the most accurate and up-to-date information.
1 Forecasted capital spend 2027-2031 in millions of CAD – USDcapital spend translated at 1.35
2Uses 2025 as a base year
3 Adjusted earnings per share (“EPS”) is a non-GAAP ratio, which does not have standardized meaning under USGAAP. For more information, refer to “Non-GAAP Financial Measures and Ratios” in Emera’s Q4 2025 MD&A which is incorporated herein by reference and can be found on SEDAR+ at www.sedarplus.ca
4Adjusted EPS growth forecast uses 2024 as base year
1 Adjusted net income is a non-GAAP measure, which does not have standardized meaning under USGAAP. For more information, refer to “Non-GAAP Financial Measures and Ratios” in Emera’s Q4 2025 MD&A which is incorporated herein by reference and can be found on SEDAR+ at www.sedarplus.ca
2 Based on 2025 adjusted net income, excluding corporate costs of $380M
4 Adjusted EPS growth forecast uses 2024 as base year
5 Forecasted capital spend and average rate base for 2027-2031 in millions of CAD. USD capital spend translated at 1.35